Sevelamer carbonate
Sevelamer Carbonate is a prescription medication available as 800 mg oral tablets. It acts as a phosphate binder to help lower high phosphate levels in the blood, commonly used for patients with chronic kidney disease on dialysis. Manufactured by Navinta LLC under ANDA219931. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Sevelamer Carbonate is a prescription medication available as 800 mg oral tablets. It acts as a phosphate binder to help lower high phosphate levels in the blood, commonly used for patients with chronic kidney disease on dialysis. Manufactured by Navinta LLC under ANDA219931. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Sevelamer carbonate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Sevelamer carbonate — ANDA 209374 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209374"
}
]
|
| identifier | ANDA209374 |
| issued | 2016-09-16 |
| keyword |
[
"drug-manufacturers",
"drug-safety",
"medications",
"pharmaceuticals",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Sevelamer carbonate |
